HCMT
ITCI

Highland Capital Management (Texas)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Highland Capital Management (Texas)’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51,666
Closed -$2.78M – 278
2015
Q4 		$2.78M Sell
51,666
-345,316
-87% -$17.4M 0.09% 159
2015
Q3 		$15.9M Buy
+396,982
New +$12.9M 0.46% 58
2014
Q2 		– Sell
-26,809
Closed -$487K – 307
2014
Q1 		$487K Buy
+26,809
New +$484K 0.02% 173

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Highland Capital Management (Texas)'s ITCI Position: Q1 2016 in Review

Highland Capital Management (Texas) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2016, closing a stake of 51,666 shares — an estimated $2.78M sold.

Highland Capital Management (Texas) first reported a position in ITCI in Q1 2014 and held it in 3 quarters. The position peaked at $15.9M in Q3 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q1 2016.

  • Highland Capital Management (Texas) reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 51,666 Intra-Cellular Therapies Inc. shares in Q1 2016, an estimated $2.78M.
  • Highland Capital Management (Texas) first reported a position in Intra-Cellular Therapies Inc. in Q1 2014 and held it in 3 quarters.
  • Highland Capital Management (Texas)'s Intra-Cellular Therapies Inc. position peaked at $15.9M in Q3 2015.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2016, filed 16 May 2016.